Aug 6, 2013Science and Technology
Indian Pharma Shake-Up

Over the past few months, starting with the Indian Supreme Court's rejection of Novartis' Glivec patent in April, big pharmaceutical companies have been experiencing some turbulence on the sub-continent. In just the past week GSK's Tykerb patent and Roche's Herceptin patent, both breast cancer drugs, have been revoked to some degree.

India partly revokes Roche cancer drug patent | Reuters
ZURICH (Reuters) - India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag
Be the first to comment.